Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Stage III Lung Non-Small Cell Cancer AJCC v7 1 Small Cell Lung Carcinoma 1 Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Temozolomide 43 Magnetic Resonance Spectroscopy 41 Radiotherapy 23 Specimen Handling 18 Biopsy 13 X-Rays 10 Radiation 10 trametinib 8 Bevacizumab 8 Nivolumab 7 Blood Specimen Collection 7 olaparib 6 fluorodopa F 18 6 dabrafenib 6 Radiotherapy, Intensity-Modulated 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 pembrolizumab 5 abemaciclib 5 Standard of Care 5 Lomustine 5 ulixertinib 4 larotrectinib 4 ivosidenib 4 erdafitinib 4 Surgical Procedures, Operative 4 Dianhydrogalactitol 4 Cyclophosphamide 4 Aminolevulinic Acid 4 vorasidenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × fluoromisonidazole × 1 year × Clear all

NCT04309552 2026-01-27

Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma

Weill Medical College of Cornell University

Phase 1 Suspended

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡